Patients dosed in Phase 1 safety and tolerability study of MDX2003, a novel T-cell engager designed to optimize killing of lymphomas Preclinical studies presented at 2025 American Society of ...

VT-1953 topical gel significantly reduced MFW-associated severe malodor over a 14 Day period (P=0.0020) as scored by ...

Results from a small randomized controlled clinical trial show promising findings about a new type of therapy for patients ...

An FDA review of records in the U.S. clinical trials database shows that results have not been reported for 30% of clinical ...

SYNGAP1 encephalopathy is a rare genetic disorder for which there is no treatment. It causes epilepsy, intellectual disability, psychomotor delay and, frequently, autism. It arises from mutations in ...

Vector-10 is a registered trademark and patented technology of Vera Clinic. All clinical data collected under institutional ...

FDA officials said an internal analysis found results were not submitted for nearly 30% of studies “highly likely” to fall ...

The search engine was released on April 13 and allows users to input details about their health history and find clinical ...

Health technology company Seqster announced Thursday the launch of its new 1-Click Sites platform, tapping BioIVT as its ...

A new method replicated the findings of a previous clinical trial of Tecfidera in people with relapsing-remitting MS, a study ...

Women have described being dismissed, disbelieved and left in serious pain during a routine womb examination that affects ...

Texas lawmakers are eyeing clinical trial for ibogaine as President Trump signed an executive order to speed up research into ...